KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Construction in Progress (2023 - 2025)

Edwards Lifesciences (EW) has 3 years of Construction in Progress data on record, last reported at $301.2 million in Q4 2025.

  • For Q4 2025, Construction in Progress rose 23.44% year-over-year to $301.2 million; the TTM value through Dec 2025 reached $301.2 million, up 23.44%, while the annual FY2025 figure was $301.2 million, 23.44% up from the prior year.
  • Construction in Progress reached $301.2 million in Q4 2025 per EW's latest filing, up from $244.0 million in the prior quarter.
  • Across five years, Construction in Progress topped out at $301.2 million in Q4 2025 and bottomed at $244.0 million in Q4 2024.
  • Average Construction in Progress over 3 years is $279.2 million, with a median of $292.5 million recorded in 2023.
  • Peak YoY movement for Construction in Progress: fell 16.58% in 2024, then increased 23.44% in 2025.
  • A 3-year view of Construction in Progress shows it stood at $292.5 million in 2023, then dropped by 16.58% to $244.0 million in 2024, then rose by 23.44% to $301.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Construction in Progress were $301.2 million in Q4 2025, $244.0 million in Q4 2024, and $292.5 million in Q4 2023.